Jupiter Asset Management LTD Biogen Inc. Transaction History

Jupiter Asset Management LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$253.3 - $285.89 $10.5 Million - $11.8 Million	41,279 New	41,279 $10.6 Million
Q1 2022 May 11, 2022	SELL	$193.77 - $244.14 $7.48 Million - $9.42 Million	-38,584 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $4.25 Million - $5.47 Million	-18,991 Reduced 32.98%	38,584 $9.26 Million
Q3 2021 Nov 10, 2021	BUY	$282.99 - $369.05 $12.2 Million - $16 Million	43,252 Added 301.98%	57,575 $16.3 Million
Q2 2021 Aug 10, 2021	BUY	$259.0 - $414.71 $3.71 Million - $5.94 Million	14,323 New	14,323 $4.96 Million
Q1 2021 May 12, 2021	SELL	$242.95 - $284.63 $16.2 Million - $19 Million	-66,719 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$236.26 - $355.63 $11.3 Million - $17 Million	47,739 Added 251.52%	66,719 $16.3 Million
Q3 2020 Nov 10, 2020	BUY	$264.77 - $305.71 $5.03 Million - $5.8 Million	18,980 New	18,980 $5.38 Million

993

131M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Jupiter Asset Management LTD with notifications on news.